Como a EMS organiza dados para pesquisar novos medicamentos com Databricks
EMS cut drug R&D cycle from 20 months to 3 months using Databricks data platform
“This reduces the working time from 1 year and 8 months to just 3 months.”
Brazilian pharma company EMS consolidated siloed data into a unified Databricks platform, enabling AI-assisted peptide design and parallel experiment planning. The result was a dramatic reduction in R&D cycle time from 20 months to 3 months. This is a vendor case study with meaningful life-sciences AI application but limited broader industry signal.